Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- UBI.AU
- Price
- 0.07
- Stock movement down
- -0.00 (-1.52%)
- Company name
- Universal Biosensors Inc.
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 19.37M
- Ent value
- 15.20M
- Price/Sales
- 2.74
- Price/Book
- 0.93
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -65.79%
- 3 year return
- -56.69%
- 5 year return
- -18.43%
- 10 year return
- -7.71%
Last updated: 2025-04-05
DIVIDENDS
UBI.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.74 |
| Price to Book | 0.93 |
| EV to Sales | 2.15 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 298.07M |
| EPS (TTM) | -0.04 |
| FCF per share (TTM) | -0.05 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 7.08M |
| Gross profit (TTM) | 3.10M |
| Operating income (TTM) | -16.16M |
| Net income (TTM) | -12.39M |
| EPS (TTM) | -0.04 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 43.76% |
| Operating margin (TTM) | -228.19% |
| Profit margin (TTM) | -175.04% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 12.38M |
| Net receivables | 2.79M |
| Total current assets | 21.73M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 35.06M |
| Total assets | 29.11M |
| Accounts payable | 855.33K |
| Short/Current long term debt | 3.38M |
| Total current liabilities | 4.32M |
| Total liabilities | 8.21M |
| Shareholder's equity | 20.90M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -14.06M |
| Capital expenditures (TTM) | 765.65K |
| Free cash flow (TTM) | -14.82M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -59.28% |
| Return on Assets | -42.57% |
| Return on Invested Capital | -56.89% |
| Cash Return on Invested Capital | -68.05% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.07 |
| Daily high | 0.07 |
| Daily low | 0.07 |
| Daily Volume | 25K |
| All-time high | 2.02 |
| 1y analyst estimate | 0.37 |
| Beta | 1.01 |
| EPS (TTM) | -0.04 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 30 May 2025 |
Downside potential
Loading...
Downside potential data
| UBI.AU | S&P500 | |
| Current price drop from All-time high | -96.78% | -17.56% |
| Highest price drop | -96.78% | -56.47% |
| Date of highest drop | 4 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -68.70% | -11.07% |
| Avg time to new high | 238 days | 12 days |
| Max time to new high | 3606 days | 1805 days |
COMPANY DETAILS
Marketcap
19.37M
Marketcap category
Small-cap
Description
Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices used in healthcare (point-of-care), wine, food, and agriculture industries in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of the anticoagulant therapy warfarin; and Sentia wine testing products, such as free SO2, malic acid, glucose, fructose, total acid, and titratable acidity. It also offers non-diagnostic laboratory services and performs coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a test strip and a meter to be used for the detection and monitoring of diabetes in non-humans. Universal Biosensors, Inc. was incorporated in 2001 and is based in Rowville, Australia.
Employees
80
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found